Department of Neuroscience/Psychiatry, Uppsala University Hospital, Ing. 15, SE-75185 Uppsala, Sweden.
Schizophr Res. 2011 Nov;132(2-3):157-64. doi: 10.1016/j.schres.2011.07.001. Epub 2011 Jul 27.
The aim of the present study was to evaluate the psychometric properties of the parallel client and clinician versions of the Illness Management and Recovery Scale (IMRS) developed to monitor the clients' progress in the Illness Management and Recovery (IMR) program in schizophrenia. A total of 107 study participants completed assessments of the IMRS, interview-based ratings of psychiatric symptoms, self-ratings of psychiatric symptoms, perception of recovery, and quality of life. Case managers completed the clinician version of the IMRS. Both versions of the scale demonstrated satisfactory internal reliability and strong test-retest reliability. The results also indicated convergent validity with interview-based ratings of psychiatric symptoms, self-rated symptoms, perception of recovery, and quality of life for both versions of the IMRS. These findings support the utility of the IMRS as a measure of illness self-management and recovery in clients with schizophrenia.
本研究旨在评估为监测精神分裂症患者在疾病管理和康复（IMR）计划中的进展而开发的平行患者和临床医生版本的疾病管理和康复量表（IMRS）的心理测量特性。共有 107 名研究参与者完成了 IMRS 的评估、基于访谈的精神症状评分、自我报告的精神症状评分、康复感知和生活质量评估。案例经理完成了 IMRS 的临床医生版本。这两个版本的量表都表现出令人满意的内部一致性和很强的重测信度。结果还表明，对于 IMRS 的两个版本，与基于访谈的精神症状评分、自我报告的症状、康复感知和生活质量均具有收敛效度。这些发现支持了 IMRS 作为衡量精神分裂症患者疾病自我管理和康复的一种手段的效用。
